Futile complete recanalization: patients characteristics and its time course.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
18 03 2020
Historique:
received: 17 10 2019
accepted: 03 03 2020
entrez: 20 3 2020
pubmed: 20 3 2020
medline: 24 11 2020
Statut: epublish

Résumé

As the goal of mechanical thrombectomy is shifting toward mTICI-3 rather than mTICI-2b, we sought to clarify the limitation of the effect of mTICI-3. A post-hoc analysis of a registry of large-vessel occlusion stroke from 46 centers was conducted. Among 2,420 registered patients, 725 patients with anterior circulation occlusion who achieved successful reperfusion were analyzed. We compared outcomes between patients with mTICI-3 and mTICI-2b, and investigated how the effect of mTICI-3 changed according to baseline characteristics and time course. The proportion of patients with favorable outcomes (mRS 0-2 at day 90) was higher among patients with mTICI-3 compared to those with mTICI-2b (adjusted OR, 2.10; 95% CI, 1.49-2.97). There was no heterogeneity in the effect of mTICI-3 with respect to age, neurological deficit, alteplase use, occluded vessels, or infarct size. mTICI-3 was associated with favorable outcomes when the puncture-to-reperfusion time was <80 minutes (adjusted OR, 2.28; 95% CI, 1.52-3.41), but not when the puncture-to-reperfusion time was ≥80 minutes. A significant heterogeneity was found in the effect of mTICI-3 reperfusion across the puncture-to-reperfusion time subgroups (P for interaction = 0.025). Until when operators should continue the procedure after mTICI-2b has been achieved, needs to be studied.

Identifiants

pubmed: 32188911
doi: 10.1038/s41598-020-61748-y
pii: 10.1038/s41598-020-61748-y
pmc: PMC7080727
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

4973

Références

Goyal, M. et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 387, 1723–1731, https://doi.org/10.1016/s0140-6736(16)00163-x (2016).
doi: 10.1016/s0140-6736(16)00163-x pubmed: 26898852
Zaidat, O. O. et al. Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke 44, 2650–2663, https://doi.org/10.1161/strokeaha.113.001972 (2013).
doi: 10.1161/strokeaha.113.001972 pubmed: 23920012 pmcid: 23920012
Yoo, A. J. et al. Refining angiographic biomarkers of revascularization: improving outcome prediction after intra-arterial therapy. Stroke 44, 2509–2512, https://doi.org/10.1161/strokeaha.113.001990 (2013).
doi: 10.1161/strokeaha.113.001990 pubmed: 23920017 pmcid: 4142767
Jayaraman, M. V., Grossberg, J. A., Meisel, K. M., Shaikhouni, A. & Silver, B. The clinical and radiographic importance of distinguishing partial from near-complete reperfusion following intra-arterial stroke therapy. AJNR Am. J. Neuroradiol. 34, 135–139, https://doi.org/10.3174/ajnr.A3278 (2013).
doi: 10.3174/ajnr.A3278 pubmed: 22837313
Dargazanli, C. et al. Impact of Modified TICI 3 versus Modified TICI 2b Reperfusion Score to Predict Good Outcome following Endovascular Therapy. Am. J. Neuroradiology 38, 90–96, https://doi.org/10.3174/ajnr.A4968 (2017).
doi: 10.3174/ajnr.A4968
Kaesmacher, J. et al. Improving mTICI2b reperfusion to mTICI2c/3 reperfusions: A retrospective observational study assessing technical feasibility, safety and clinical efficacy. Eur. radiology 28, 274–282, https://doi.org/10.1007/s00330-017-4928-3 (2018).
doi: 10.1007/s00330-017-4928-3
Goyal, N. et al. Comparative Safety and Efficacy of Modified TICI 2b and TICI 3 Reperfusion in Acute Ischemic Strokes Treated With Mechanical Thrombectomy. Neurosurg. 84, 680–686, https://doi.org/10.1093/neuros/nyy097 (2019).
doi: 10.1093/neuros/nyy097
Chamorro, A. et al. Complete reperfusion is required for maximal benefits of mechanical thrombectomy in stroke patients. Sci. Rep. 7, 11636, https://doi.org/10.1038/s41598-017-11946-y (2017).
doi: 10.1038/s41598-017-11946-y pubmed: 28912596 pmcid: 5599658
Dargazanli, C. et al. Modified Thrombolysis in Cerebral Infarction 2C/Thrombolysis in Cerebral Infarction 3 Reperfusion Should Be the Aim of Mechanical Thrombectomy: Insights From the ASTER Trial (Contact Aspiration Versus Stent Retriever for Successful Revascularization). Stroke 49, 1189–1196, https://doi.org/10.1161/strokeaha.118.020700 (2018).
doi: 10.1161/strokeaha.118.020700 pubmed: 29626134
Tung, E. L. et al. Rethinking Thrombolysis in Cerebral Infarction 2b: Which Thrombolysis in Cerebral Infarction Scales Best Define Near Complete Recanalization in the Modern Thrombectomy Era? Stroke 48, 2488–2493, https://doi.org/10.1161/strokeaha.117.017182 (2017).
doi: 10.1161/strokeaha.117.017182 pubmed: 28775136
Kaesmacher, J. et al. Systematic review and meta-analysis on outcome differences among patients with TICI2b versus TICI3 reperfusions: success revisited. J. neurology, neurosurgery, psychiatry 89, 910–917, https://doi.org/10.1136/jnnp-2017-317602 (2018).
doi: 10.1136/jnnp-2017-317602
Rizvi, A. et al. Redefining ‘success’: a systematic review and meta-analysis comparing outcomes between incomplete and complete revascularization. J. Neurointerv Surg. 11, 9–13, https://doi.org/10.1136/neurintsurg-2018-013950 (2019).
doi: 10.1136/neurintsurg-2018-013950 pubmed: 29802163
Kleine, J. F., Wunderlich, S., Zimmer, C. & Kaesmacher, J. Time to redefine success? TICI 3 versus TICI 2b recanalization in middle cerebral artery occlusion treated with thrombectomy. J. Neurointerv Surg. 9, 117–121, https://doi.org/10.1136/neurintsurg-2015-012218 (2017).
doi: 10.1136/neurintsurg-2015-012218 pubmed: 26888952
Almekhlafi, M. A. et al. Not all “successful” angiographic reperfusion patients are an equal validation of a modified TICI scoring system. Interventional neuroradiology: J. peritherapeutic neuroradiology, surgical Proced. Relat. Neurosci. 20, 21–27, https://doi.org/10.15274/inr-2014-10004 (2014).
doi: 10.15274/inr-2014-10004
Carvalho, A. et al. Time to Reset the Definition of Successful Revascularization in Endovascular Treatment of Acute Ischemic Stroke. Cerebrovasc. Dis. 46, 40–45, https://doi.org/10.1159/000491553 (2018).
doi: 10.1159/000491553 pubmed: 30064126
Behme, D. et al. Impact of Time on Thrombolysis in Cerebral Infarction Score Results. Clinical neuroradiology, https://doi.org/10.1007/s00062-019-00786-0 (2019).
Saver, J. L. et al. Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysisEndovascular Thrombectomy and Outcomes in Ischemic Stroke Endovascular Thrombectomy and Outcomes in Ischemic Stroke. Jama 316, 1279–1289, https://doi.org/10.1001/jama.2016.13647 (2016).
doi: 10.1001/jama.2016.13647 pubmed: 27673305
van Swieten, J. C., Koudstaal, P. J., Visser, M. C., Schouten, H. J. & van Gijn, J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19, 604–607 (1988).
doi: 10.1161/01.STR.19.5.604
Wahlgren, N. et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 369, 275–282, https://doi.org/10.1016/s0140-6736(07)60149-4 (2007).
doi: 10.1016/s0140-6736(07)60149-4 pubmed: 17258667
Powers, W. J. et al. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 49, e46–e110, https://doi.org/10.1161/str.0000000000000158 (2018).
doi: 10.1161/str.0000000000000158 pubmed: 29367334 pmcid: 29367334
Kaesmacher, J. et al. Mechanical Thrombectomy in Ischemic Stroke Patients With Alberta Stroke Program Early Computed Tomography Score 0–5. Stroke 50, 880–888, https://doi.org/10.1161/STROKEAHA.118.023465 (2019).
doi: 10.1161/STROKEAHA.118.023465 pubmed: 30827193 pmcid: 6430594
Dekker, L. et al. Importance of Reperfusion Status after Intra-Arterial Thrombectomy for Prediction of Outcome in Anterior Circulation Large Vessel Stroke. Interventional Neurol. 7, 137–147, https://doi.org/10.1159/000486246 (2018).
doi: 10.1159/000486246
Carvalho, A. et al. Need for refining successful revascularization in endovascular treatment of acute ischemic stroke: Data from real-world. J. Neurol. Sci. 384, 129–132, https://doi.org/10.1016/j.jns.2017.10.013 (2018).
doi: 10.1016/j.jns.2017.10.013 pubmed: 29066135
Linfante, I. et al. Predictors of poor outcome despite recanalization: a multiple regression analysis of the NASA registry. J. NeuroInterventional Surg. 8, 224–229, https://doi.org/10.1136/neurintsurg-2014-011525 (2016).
doi: 10.1136/neurintsurg-2014-011525
Fisher, M. & Bastan, B. Identifying and utilizing the ischemic penumbra. Neurol. 79, S79–85, https://doi.org/10.1212/WNL.0b013e3182695814 (2012).
doi: 10.1212/WNL.0b013e3182695814
Marks, M. P. et al. Endovascular Treatment in the DEFUSE 3 Study. Stroke 49, 2000–2003, https://doi.org/10.1161/strokeaha.118.022147 (2018).
doi: 10.1161/strokeaha.118.022147 pubmed: 29986935 pmcid: 6202142
Spokoyny, I. et al. Accuracy of First Recorded “Last Known Normal” Times of Stroke Code Patients. J. Stroke Cerebrovasc. Dis. 24, 2467–2473, https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.04.041 (2015).
doi: 10.1016/j.jstrokecerebrovasdis.2015.04.041 pubmed: 26341734 pmcid: 4630074
Zhang, G. et al. Operator Versus Core Lab Adjudication of Reperfusion After Endovascular Treatment of Acute Ischemic Stroke. Stroke 49, 2376–2382, https://doi.org/10.1161/strokeaha.118.022031 (2018).
doi: 10.1161/strokeaha.118.022031 pubmed: 30355107
Fahed, R. et al. Agreement between core laboratory and study investigators for imaging scores in a thrombectomy trial. J. Neurointerv Surg. 10, e30, https://doi.org/10.1136/neurintsurg-2018-013867 (2018).
doi: 10.1136/neurintsurg-2018-013867 pubmed: 29760012
Goyal, M. et al. 2C or not 2C: defining an improved revascularization grading scale and the need for standardization of angiography outcomes in stroke trials. J. Neurointerv Surg. 6, 83–86, https://doi.org/10.1136/neurintsurg-2013-010665 (2014).
doi: 10.1136/neurintsurg-2013-010665 pubmed: 23390038
Liebeskind, D. S. et al. eTICI reperfusion: defining success in endovascular stroke therapy. J. Neurointerv Surg. 11, 433–438, https://doi.org/10.1136/neurintsurg-2018-014127 (2019).
doi: 10.1136/neurintsurg-2018-014127 pubmed: 30194109
Alawieh, A. et al. Impact of Procedure Time on Outcomes of Thrombectomy for Stroke. J. Am. Coll. Cardiol. 73, 879–890, https://doi.org/10.1016/j.jacc.2018.11.052 (2019).
doi: 10.1016/j.jacc.2018.11.052 pubmed: 30819354

Auteurs

Takaya Kitano (T)

Stroke Center, Osaka University Hospital, Osaka, Japan.

Kenichi Todo (K)

Stroke Center, Osaka University Hospital, Osaka, Japan. ktodo@neurol.med.osaka-u.ac.jp.

Shinichi Yoshimura (S)

Department of Neurosurgery, Hyogo College of Medicine, Hyogo, Japan.

Kazutaka Uchida (K)

Department of Neurosurgery, Hyogo College of Medicine, Hyogo, Japan.

Hiroshi Yamagami (H)

Division of Stroke Care Unit, National Cerebral and Cardiovascular Center, Osaka, Japan.

Nobuyuki Sakai (N)

Department of Neurosurgery, Kobe City Medical Center General Hospital, Hyogo, Japan.

Manabu Sakaguchi (M)

Stroke Center, Osaka University Hospital, Osaka, Japan.

Hajime Nakamura (H)

Stroke Center, Osaka University Hospital, Osaka, Japan.

Haruhiko Kishima (H)

Stroke Center, Osaka University Hospital, Osaka, Japan.

Hideki Mochizuki (H)

Stroke Center, Osaka University Hospital, Osaka, Japan.

Masayuki Ezura (M)

Department of Neurosurgery, National Hospital Organization Sendai Medical Center, Miyagi, Japan.

Yasushi Okada (Y)

Department of Cerebrovascular Medicine and Neurology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.

Kazuo Kitagawa (K)

Department of Neurology, Tokyo Women's Medical University, Tokyo, Japan.

Kazumi Kimura (K)

Department of Neurology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.

Makoto Sasaki (M)

Institute for Biomedical Sciences, Iwate Medical University, Iwate, Japan.

Norio Tanahashi (N)

Department of Neurology, Saitama Medical University International Medical Center, Saitama, Japan.

Kazunori Toyoda (K)

Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.

Eisuke Furui (E)

Department of Stroke Neurology, Saiseikai Toyama Hospital, Toyama, Japan.

Yuji Matsumaru (Y)

Division of stroke prevention and treatment, Department of Neurosurgery, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.

Kazuo Minematsu (K)

Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.

Takeshi Morimoto (T)

Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH